Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
AI agents are powerful, but without a strong control plane and hard guardrails, they’re just one bad decision away from chaos.
RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...
Hosted on MSN
DNS is the most powerful tool in your home lab
Out of all the tools available to home labbers, I think local DNS servers are the most powerful. I've used many variants, from PowerDNS to Technitium, Unbound, BIND9, and CoreDNS, each with its own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results